- Home
- VMI vs OGN Comparison
VMI vs OGN Comparison
Compare VMI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMI
- OGN
- Stock Information
- Founded
- VMI 1946
- OGN 1923
- Country
- VMI United States
- OGN United States
- Employees
- VMI N/A
- OGN N/A
- Industry
- VMI Metal Fabrications
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- VMI Industrials
- OGN Health Care
- Exchange
- VMI Nasdaq
- OGN Nasdaq
- Market Cap
- VMI 6.2B
- OGN 3.9B
- IPO Year
- VMI N/A
- OGN N/A
- Fundamental
- Price
- VMI $305.47
- OGN $14.96
- Analyst Decision
- VMI Strong Buy
- OGN Hold
- Analyst Count
- VMI 2
- OGN 3
- Target Price
- VMI $381.00
- OGN $21.33
- AVG Volume (30 Days)
- VMI 123.9K
- OGN 4.5M
- Earning Date
- VMI 02-19-2025
- OGN 02-13-2025
- Dividend Yield
- VMI 0.78%
- OGN 7.56%
- EPS Growth
- VMI 101.97
- OGN 120.97
- EPS
- VMI 14.66
- OGN 5.04
- Revenue
- VMI $4,053,266,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- VMI N/A
- OGN $3.11
- Revenue Next Year
- VMI $2.74
- OGN $1.84
- P/E Ratio
- VMI $20.82
- OGN $2.97
- Revenue Growth
- VMI N/A
- OGN 4.21
- 52 Week Low
- VMI $202.01
- OGN $13.65
- 52 Week High
- VMI $354.13
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- VMI 31.69
- OGN 46.29
- Support Level
- VMI $301.95
- OGN $14.57
- Resistance Level
- VMI $311.61
- OGN $15.12
- Average True Range (ATR)
- VMI 6.31
- OGN 0.51
- MACD
- VMI -1.89
- OGN 0.07
- Stochastic Oscillator
- VMI 11.03
- OGN 52.40
About VMI Valmont Industries Inc.
Valmont Industries Inc is an investment holding company. It operates through two segments namely Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment. The infrastructure segment consists of the manufacture and distribution of products and solutions to serve the infrastructure markets of utility, renewable energy, lighting, transportation, and telecommunications, and coatings services to preserve metal products. Geographically, it derives a majority of its revenue from North America.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.